World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 April 2021
Main ID:  NCT01058252
Date of registration: 27/01/2010
Prospective Registration: Yes
Primary sponsor: Galaxy Pharma (Pvt) Limited
Public title: Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF MSP-INVO IVF
Scientific title: A Scientific & Clinical Review of Minimal Stimulation Protocol Using AROMEK (Letrozole) and Follitrope (Recombinant FSH)Combined With INVOCell(Intravaginal Culturing) - Effectiveness as Low Cost IVF
Date of first enrolment: May 2021
Target sample size: 30
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT01058252
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Pakistan
Contacts
Name:     Dr Gul Rana, MBBS
Address: 
Telephone: +923353039246
Email: gulrana8@gmail.com
Affiliation: 
Name:     Dr Gul Rana, MBBS
Address: 
Telephone:
Email:
Affiliation:  Ova IVF & Reproductive Health Clinics
Key inclusion & exclusion criteria

Inclusion Criteria:

- Tubal factor without Hydrosalpinx

- Unexplained infertility with unsuccessful attempts in achieving pregnancy through
timed intercourse or IUI

- Boarder line male factor infertility

- Sperm DNA Fragmentation < 30%

- Normal Uterine Cavity

- Normal baseline ultrasound with adequate number of primary follicles present

- Normal FSH and E2 on Day 3

- Age of the female is < 35 years old

Exclusion Criteria:

- If previous IVF or INVO attempts resulted in failed fertilisation

- Male partner who has difficulty in producing semen sample

- Very low sperm count, very low percentage of sperm motility and morphology

- Sperm DNA Fragmentation > 30%

- Age of female patient > 37 years

- Borderline or elevated E2 or FSH on day 3 or failed CCCT or low blood inhibin levels

- Poor ovarian response

- Hydrosalpinx

- Anatomic difficulties in reaching ovaries for oocyte retrieval

- Cervical stenosis, making embryo transfer difficult

- Uterine abnormalities or deformities

- Obesity



Age minimum: 20 Years
Age maximum: 37 Years
Gender: All
Health Condition(s) or Problem(s) studied
Secondary Infertility
Mild to Moderate Male Factor Infertility
Primary Infertility
Low Responders
Intervention(s)
Procedure: STEP-5: OPU, ET, Cancellation
Procedure: STEP-3: LH Suppression & Monitoring
Procedure: STEP-4: HCG Timing
Combination Product: INVOCell, Letrozole 2.5 mg, recFSH 75 IU
Procedure: INVOCell (Intravaginal Culturing)
Primary Outcome(s)
Number of Follicles >18 mm on the day of HCG; Number of Oocytes aspirated; Fertilisation Rate [Time Frame: Quarterly]
Secondary Outcome(s)
Pregnancy Rate; Cost of Treatment [Time Frame: Every 6 months]
Secondary ID(s)
GIVF-SRM 1001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ova IVF & Reproductive Health Clinics, Karachi
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history